1. Home
  2. OMH vs NRSN Comparison

OMH vs NRSN Comparison

Compare OMH & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

N/A

Current Price

$0.99

Market Cap

24.4M

Sector

Finance

ML Signal

N/A

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.96

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMH
NRSN
Founded
2015
2017
Country
Singapore
Israel
Employees
N/A
16
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.4M
26.5M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
OMH
NRSN
Price
$0.99
$0.96
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
20.7K
135.9K
Earning Date
05-12-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$28.40
N/A
Revenue Next Year
$23.07
$583.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$0.63
52 Week High
$3.28
$2.60

Technical Indicators

Market Signals
Indicator
OMH
NRSN
Relative Strength Index (RSI) 40.76 74.97
Support Level $0.98 $0.84
Resistance Level $1.38 $1.06
Average True Range (ATR) 0.08 0.05
MACD 0.00 0.03
Stochastic Oscillator 42.31 100.00

Price Performance

Historical Comparison
OMH
NRSN

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: